Section Arrow
Quote
ISPC.NASDAQ
- iSpecimen Inc
(Financial Status)
Quotes are at least 15-min delayed:2025/09/17 16:59 EDT
After Hours
Last
 1.63
+0.03 (+1.88%)
Bid
1.62
Ask
1.63
High 1.65 
Low 1.59 
Volume 29312 
Regular Hours
Last
 1.6
-0.09 (-5.33%)
Day High 
1.77 
Prev. Close
1.69 
1-M High
3.18 
Volume 
2.16M 
Bid
1.62
Ask
1.63
Day Low
1.545 
Open
1.55 
1-M Low
0.64 
Market Cap 
13.88M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.29 
20-SMA 1.06 
50-SMA 1.14 
52-W High 8.3 
52-W Low 0.64 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-8.91/--
Enterprise Value
14.15M
Balance Sheet
Book Value Per Share
0.08
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.29M
Operating Revenue Per Share
1.26
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
BIAFbioAffinity Technologies0.1826-0.0784-30.04%-- 
After Hours 0.1805 -0.0021 -1.15%
NEOGNeogen Corp5.46+0.19+3.61%879PE
After Hours 5.46 0 0.00%
DHRDanaher Corp192.94+2.47+1.30%40.44PE
After Hours 193.25 +0.31 +0.16%
NEONeoGenomics8.11+0.12+1.50%-- 
After Hours 8.06 -0.05 -0.62%
CHEKCheck-Cap Ltd2.32-0.2-7.94%-- 
After Hours 2.37 +0.05 +2.16%
Quotes are at least 15-min delayed：2025/09/17 16:59 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.